BioSig Technologies, Inc. entered into a security purchase agreement for the issuance of 2,178,316 shares at a price of $0.57608 per share for gross proceeds of $1,254,884.28128 on January 10, 2023. The transaction included participation from certain institutional and accredited investors. The company has also issued warrants to purchase up to 1,089,158 shares, at an exercise price of $0.51358 per share, that will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance.

The securities were offered and sold in reliance on the exemption from registration under the Securities Act of 1933, as amended provided by Section 4(a)(2) and Regulation D (Rule 506) under the Securities Act. The transaction included participation from total 17 investors.